Table 1.
Comparison of patient age, HPV infection status and TCT test results.
| Variable | C Group (N = 27) | CIN Group (N = 22) | CER Group (N = 23) | P value |
|---|---|---|---|---|
| Percentage of total enrollment, | 27(37.5) | 22(30.56) | 23(31.94) | / |
| No (%). | ||||
| Age (mean ± std. deviation) | 34.04 ± 3.142 | 35.53 ± 2.951 | 34.16 ± 1.914 | 0.1374 |
| TCT result category, No (%). | <0.0001 | |||
| NILM | 27 (100%) | 9 (40.91%) | 1 (4.34%) | |
| LSIL | 0 (0%) | 3 (13.63%) | 2 (8.69%) | |
| HSIL | 0 (0%) | 5 (22.73%) | 9 (39.14%) | |
| ASC | 0 (0%) | 5 (22.73%) | 7 (30.44%) | |
| Squamous cell carcinoma | 0 (0%) | 0 (0%) | 4 (17.39%) | |
| HPV infection subtype, No (%). | <0.0001 | |||
| Negative | 27(100%) | 2(9.09%) | 1(4.35%) | |
| 16 or 18 | 0(0%) | 13(59.09%) | 19(82.61%) | |
| Others | 0(0%) | 7(31.82%) | 3(13.04%) | |
Age differences between groups are not statistically significant (P = 0.1347). The rates of high-risk HPV infection and abnormal rates of TCT in the CER and CIN groups were higher than those in the C group (P<0.0001). P value less than 0.05 is statistically significant.
C group, healthy control group; CIN group, Cervical intraepithelial neoplasis group; CER group, Cervical cancer group; NILM, No intraepithelial lesions and malignant lesions; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; ASC, atypical squamous cell.